Dr. Hamdi Eryilmaz, Ph.D.
Claim this profileStudies Working Memory
1 reported clinical trial
2 drugs studied
Clinical Trials Hamdi Eryilmaz, Ph.D. is currently running
More about Hamdi Eryilmaz, Ph.D.
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Hamdi Eryilmaz, Ph.D. has experience with
- Active TACS
- Placebo TACS
Breakdown of trials Hamdi Eryilmaz, Ph.D. has run
Working Memory
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hamdi Eryilmaz, Ph.D. specialize in?
Hamdi Eryilmaz, Ph.D. focuses on Working Memory and other conditions. In particular, much of their work with Working Memory has involved treating patients, or patients who are undergoing treatment.
Is Hamdi Eryilmaz, Ph.D. currently recruiting for clinical trials?
Yes, Hamdi Eryilmaz, Ph.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Hamdi Eryilmaz, Ph.D. has studied deeply?
Yes, Hamdi Eryilmaz, Ph.D. has studied treatments such as Active tACS, Placebo tACS.
What is the best way to schedule an appointment with Hamdi Eryilmaz, Ph.D.?
Apply for one of the trials that Hamdi Eryilmaz, Ph.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.